Cargando…
3′-Phosphoadenosine 5′-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents
Standard treatment for advanced non-small cell lung cancer (NSCLC) with no known driver mutation is platinum-based chemotherapy, which has a response rate of only 30–33%. Through an siRNA screen, 3′-phosphoadenosine 5′-phosphosulfate (PAPS) synthase 1 (PAPSS1), an enzyme that synthesizes the biologi...
Autores principales: | Leung, Ada W. Y., Dragowska, Wieslawa H., Ricaurte, Daniel, Kwok, Brian, Mathew, Veena, Roosendaal, Jeroen, Ahluwalia, Amith, Warburton, Corinna, Laskin, Janessa J., Stirling, Peter C., Qadir, Mohammed A., Bally, Marcel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627299/ https://www.ncbi.nlm.nih.gov/pubmed/26220590 |
Ejemplares similares
-
Analysis of the Human 3’-Phosphoadenosine 5’-Phosphosulfate Synthase Genes
por: Campbell, W.G., et al.
Publicado: (2002) -
3′-Phosphoadenosine
5′-Phosphosulfate
Allosterically Regulates Sulfotransferase Turnover
por: Wang, Ting, et al.
Publicado: (2014) -
3′-Phosphoadenosine 5′-Phosphosulfate (PAPS) Synthases, Naturally Fragile Enzymes Specifically Stabilized by Nucleotide Binding
por: van den Boom, Johannes, et al.
Publicado: (2012) -
Bacterial Over-Expression and Purification of the 3′phosphoadenosine 5′phosphosulfate (PAPS) Reductase Domain of Human FAD Synthase: Functional Characterization and Homology Modeling
por: Miccolis, Angelica, et al.
Publicado: (2012) -
The 3′-Phosphoadenosine 5′-Phosphosulfate Transporters, PAPST1 and 2, Contribute to the Maintenance and Differentiation of Mouse Embryonic Stem Cells
por: Sasaki, Norihiko, et al.
Publicado: (2009)